Cite
A multidrug resistance-associated protein inhibitor is a potential enhancer of the benzyl isothiocyanate-induced apoptosis induction in human colorectal cancer cells.
MLA
Yang, Qifu, et al. “A Multidrug Resistance-Associated Protein Inhibitor Is a Potential Enhancer of the Benzyl Isothiocyanate-Induced Apoptosis Induction in Human Colorectal Cancer Cells.” Journal of Biochemical and Molecular Toxicology, vol. 35, no. 7, July 2021, p. e22791. EBSCOhost, https://doi.org/10.1002/jbt.22791.
APA
Yang, Q., Nakamura, T., Seto, M., Miyagawa, M., Xu, W., Zhu, B., Munemasa, S., Murata, Y., & Nakamura, Y. (2021). A multidrug resistance-associated protein inhibitor is a potential enhancer of the benzyl isothiocyanate-induced apoptosis induction in human colorectal cancer cells. Journal of Biochemical and Molecular Toxicology, 35(7), e22791. https://doi.org/10.1002/jbt.22791
Chicago
Yang, Qifu, Toshiyuki Nakamura, Masayuki Seto, Miku Miyagawa, Wensi Xu, Beiwei Zhu, Shintaro Munemasa, Yoshiyuki Murata, and Yoshimasa Nakamura. 2021. “A Multidrug Resistance-Associated Protein Inhibitor Is a Potential Enhancer of the Benzyl Isothiocyanate-Induced Apoptosis Induction in Human Colorectal Cancer Cells.” Journal of Biochemical and Molecular Toxicology 35 (7): e22791. doi:10.1002/jbt.22791.